Sunmax Biotechnology Co., Ltd.
TWO: 4728.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ming Yi Lin
- Headquarters
- Tainan City, Taiwan
- IPO year
- 2012
- Market cap
- NT$20.8B
- Website
- https://www.sunmaxbiotech.com
Loading 4728…
Loading profile data…Frequently asked questions about 4728
What does Sunmax Biotechnology Co., Ltd. (4728.TWO) do?
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China. The company offers Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes; and dermal fillers, such as Sunmax collagen implant I-Plus, Sumax c...
Where does 4728.TWO trade?
Sunmax Biotechnology Co., Ltd. (4728.TWO) trades on the Taipei Exchange.
What sector is 4728.TWO in?
Sunmax Biotechnology Co., Ltd. (4728.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sunmax Biotechnology Co., Ltd.?
Ming Yi Lin is the chief executive officer of Sunmax Biotechnology Co., Ltd. (4728.TWO).
Where is Sunmax Biotechnology Co., Ltd. headquartered?
Sunmax Biotechnology Co., Ltd. is headquartered in Taiwan.
Does 4728.TWO pay a dividend?
Yes — Sunmax Biotechnology Co., Ltd. (4728.TWO) paid a trailing twelve-month dividend of TWD 23.70 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4728.TWO go public?
Sunmax Biotechnology Co., Ltd. (4728.TWO) completed its initial public offering in 2012.